Home/Filings/4/0001437749-15-009013
4//SEC Filing

HYPERION THERAPEUTICS INC 4

Accession 0001437749-15-009013

CIK 0001386858operating

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:35 PM ET

Size

10.6 KB

Accession

0001437749-15-009013

Insider Transaction Report

Form 4
Period: 2015-05-01
Scharschmidt Bruce Frederick
SVP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2015-05-01$4.08/sh+2,186$8,91999,669 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2015-05-012,1860 total
    Exercise: $4.08Exp: 2021-04-14Common Stock (2,186 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2015-05-014,78925,227 total
    Exercise: $7.31Exp: 2022-04-15Common Stock (4,789 underlying)
  • Exercise/Conversion

    Common Stock

    2015-05-01$7.31/sh+4,789$35,008104,458 total
Holdings
  • Common Stock

    (indirect: By Trust)
    24,436
Footnotes (1)
  • [F1]The option was vested and exercisable on the date of exercise.

Issuer

HYPERION THERAPEUTICS INC

CIK 0001386858

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001386858

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:35 PM ET
Size
10.6 KB